Yangyang Ma

503 total citations
40 papers, 301 citations indexed

About

Yangyang Ma is a scholar working on Surgery, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, Yangyang Ma has authored 40 papers receiving a total of 301 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Surgery, 12 papers in Pathology and Forensic Medicine and 11 papers in Oncology. Recurrent topics in Yangyang Ma's work include Vascular Malformations and Hemangiomas (5 papers), Neuroblastoma Research and Treatments (5 papers) and Sarcoma Diagnosis and Treatment (5 papers). Yangyang Ma is often cited by papers focused on Vascular Malformations and Hemangiomas (5 papers), Neuroblastoma Research and Treatments (5 papers) and Sarcoma Diagnosis and Treatment (5 papers). Yangyang Ma collaborates with scholars based in China, Laos and Thailand. Yangyang Ma's co-authors include Shan Zheng, Lian Chen, Xianmin Xiao, Zuopeng Wang, Jicui Zheng, Wei Yao, Hongqiang Sun, Gong Chen, Kai Li and Kuiran Dong and has published in prestigious journals such as SHILAP Revista de lepidopterología, Molecules and Bone.

In The Last Decade

Yangyang Ma

37 papers receiving 296 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yangyang Ma China 9 161 81 70 58 57 40 301
Thibault Desurmont France 8 162 1.0× 47 0.6× 39 0.6× 42 0.7× 65 1.1× 11 301
Ji Young Joung South Korea 15 126 0.8× 29 0.4× 41 0.6× 37 0.6× 29 0.5× 23 428
Katarzyna Urbańczyk Poland 9 162 1.0× 175 2.2× 32 0.5× 27 0.5× 43 0.8× 29 343
Remei Blanco Spain 9 149 0.9× 330 4.1× 59 0.8× 24 0.4× 83 1.5× 18 465
Khurram Minhas Pakistan 8 55 0.3× 48 0.6× 33 0.5× 52 0.9× 53 0.9× 40 231
Ece Dilege Türkiye 10 194 1.2× 103 1.3× 44 0.6× 16 0.3× 52 0.9× 20 314
Daoyuan Si China 11 74 0.5× 35 0.4× 73 1.0× 13 0.2× 36 0.6× 38 355
Asimina Gaglia Greece 11 116 0.7× 60 0.7× 43 0.6× 23 0.4× 124 2.2× 21 333
Paolo Brazzarola Italy 9 150 0.9× 33 0.4× 37 0.5× 11 0.2× 29 0.5× 24 307
Chih‐Yuan Fang Taiwan 12 96 0.6× 85 1.0× 74 1.1× 16 0.3× 37 0.6× 15 283

Countries citing papers authored by Yangyang Ma

Since Specialization
Citations

This map shows the geographic impact of Yangyang Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yangyang Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yangyang Ma more than expected).

Fields of papers citing papers by Yangyang Ma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yangyang Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yangyang Ma. The network helps show where Yangyang Ma may publish in the future.

Co-authorship network of co-authors of Yangyang Ma

This figure shows the co-authorship network connecting the top 25 collaborators of Yangyang Ma. A scholar is included among the top collaborators of Yangyang Ma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yangyang Ma. Yangyang Ma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ma, Yangyang, Xinxin Chen, Yan Liang, et al.. (2025). The granulomatous pulmonary nodules induced by tislelizumab in advanced squamous NSCLC: a case report with challenging differential diagnosis. Translational Lung Cancer Research. 14(10). 4675–4681.
2.
Zhao, J., et al.. (2024). Clinicopathological Features of Pediatric Insulinoma: A Single-Centre Study. British Journal of Hospital Medicine. 85(7). 1–13. 1 indexed citations
3.
Ma, Yangyang, et al.. (2024). Palladium-catalyzed NHC ligand-controlled regiodivergent allyl-fluoroallyl cross-couplings. Organic Chemistry Frontiers. 12(3). 760–765.
4.
Hu, Shiwen, Zifeng Li, Hongsheng Wang, et al.. (2023). Clinical features and treatment outcomes of Castleman disease in children: a retrospective cohort in China. European Journal of Pediatrics. 182(12). 5519–5530. 3 indexed citations
5.
Wang, Zuopeng, et al.. (2023). Case Report: Kaposiform hemangioendothelioma with PIK3CA mutation successfully treated with sirolimus. Frontiers in Oncology. 13. 1132702–1132702. 4 indexed citations
6.
Man, Jie, Hongsheng Wang, Xiaowen Qian, et al.. (2022). TCF3 protein was highly expressed in pediatric Burkitt lymphoma and predicts poor prognosis: a single-center study. Leukemia & lymphoma. 63(10). 2453–2460. 1 indexed citations
7.
Wang, Zuopeng, Ping Xu, Yangyang Ma, et al.. (2022). MRI-based radiomics in distinguishing Kaposiform hemangioendothelioma (KHE) and fibro-adipose vascular anomaly (FAVA) in extremities: A preliminary retrospective study. Journal of Pediatric Surgery. 57(7). 1228–1234. 5 indexed citations
8.
Yang, Dehong, et al.. (2022). Is removal of the internal fixation after successful intervertebral fusion necessary? A case–control study based on patient-reported quality of life. Journal of Orthopaedic Surgery and Research. 17(1). 141–141. 2 indexed citations
9.
Yang, Hong, Yangyang Ma, Shaobo Yang, Yanlei Huang, & Gong Chen. (2021). Skip segment Hirschsprung’s disease: report of two rare cases and management. Pediatric Surgery International. 37(11). 1563–1568. 1 indexed citations
10.
Wang, Zuopeng, Chao Zheng, Hongqiang Sun, et al.. (2020). Immunohistochemical Analysis of mTOR Pathway-Related Proteins in Kaposiform Hemangioendothelioma. Dermatology. 236(3). 262–270. 12 indexed citations
11.
12.
Wang, Zuopeng, Hongqiang Sun, Kai Li, et al.. (2019). Prognostic factor analysis of stage 4S neuroblastoma in infant patients: A single center study. Journal of Pediatric Surgery. 54(12). 2585–2588. 4 indexed citations
13.
Zheng, Shan, Xuexin Lu, Gong Chen, et al.. (2018). Clinical and pathological features of patients with biliary atresia who survived for more than 5 years with native liver. Pediatric Surgery International. 34(4). 381–386. 8 indexed citations
14.
Li, Jiwei, Yangyang Ma, Baihui Liu, et al.. (2015). Persistent hyperinsulinemic hypoglycemia of infancy: a clinical and pathological study of 19 cases in a single institution.. PubMed. 8(11). 14417–24. 4 indexed citations
15.
Gong, Ying, et al.. (2015). Focal nodular hyperplasia coexistent with hepatoblastoma in a 36-d-old infant. World Journal of Gastroenterology. 21(3). 1028–1028. 2 indexed citations
16.
Yang, Shaobo, et al.. (2015). Signet-ring cell carcinoma of the colon: A case report of a 9-year-old boy. Oncology Letters. 10(3). 1632–1634. 6 indexed citations
17.
Chen, Gong, Ping Xue, Shan Zheng, Lian Chen, & Yangyang Ma. (2015). A pathological scoring system in the diagnosis and judgment of prognosis of biliary atresia. Journal of Pediatric Surgery. 50(12). 2119–2123. 23 indexed citations
18.
Yao, Wei, Kai Li, Shan Zheng, et al.. (2013). Knockdown of β-catenin expression inhibits neuroblastoma cell growth in vitro and in vivo. Journal of Pediatric Surgery. 48(12). 2466–2473. 7 indexed citations
19.
Zheng, Jicui, Hui Li, Haitao Zhu, Xianmin Xiao, & Yangyang Ma. (2013). Genistein inhibits estradiol- and environmental endocrine disruptor-induced growth effects on neuroblastoma cells in vitro. Oncology Letters. 5(5). 1583–1586. 6 indexed citations
20.
Chen, Gong, Shan Zheng, Xianmin Xiao, et al.. (2012). Early surgical outcomes and pathological scoring values of older infants (≥90 d old) with biliary atresia. Journal of Pediatric Surgery. 47(12). 2184–2188. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Thibault Desurmont Breakdown of academic impact, for papers by Ji Young Joung Breakdown of academic impact, for papers by Katarzyna Urbańczyk Breakdown of academic impact, for papers by Remei Blanco Breakdown of academic impact, for papers by Khurram Minhas Breakdown of academic impact, for papers by Ece Dilege Breakdown of academic impact, for papers by Daoyuan Si Breakdown of academic impact, for papers by Asimina Gaglia Breakdown of academic impact, for papers by Paolo Brazzarola Breakdown of academic impact, for papers by Chih‐Yuan Fang
Rankless by CCL
2026